Lamiae Grimaldi‐Bensouda
Inserm(FR)Université de Versailles Saint-Quentin-en-Yvelines(FR)Université Paris-Saclay(FR)Assistance Publique – Hôpitaux de Paris(FR)Assistance Publique – Hôpitaux de Paris(FR)Institut Fresnel(FR)Hôpital Ambroise-Paré(FR)Bicêtre Hospital(FR)
Publications by Year
Research Areas
Health Systems, Economic Evaluations, Quality of Life, Pharmacovigilance and Adverse Drug Reactions, SARS-CoV-2 and COVID-19 Research, Complementary and Alternative Medicine Studies, Neurogenetic and Muscular Disorders Research
Most-Cited Works
- → Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia(2020)773 cited
- → Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial(2021)294 cited
- → Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (RACE): a multicentre, phase 3, open-label, randomised controlled trial and ancillary follow-up study(2022)211 cited
- → Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)(2012)201 cited
- → Eculizumab as an emergency treatment for adult patients with severe COVID-19 in the intensive care unit: A proof-of-concept study(2020)180 cited
- → Autoimmune disorders and quadrivalent human papillomavirus vaccination of young female subjects